Therapeutic trial of low density lipoprotein apheresis (LDL-A) in conjunction with double filtration plasmapheresis (DFPP) in drug-resistant nephrotic syndrome due to focal glomerular sclerosis (FGS).
Tojo
K
K
2nd Department of Medicine, Jikei University School of Medicine, Tokyo, Japan.
Sakai
S
S
Miyahara
T
T
D000293:Adolescent; D000328:Adult; D001781:Blood Component Removal / Q000379:methods*; D002986:Clinical Trials as Topic; D004351:Drug Resistance; D005260:Female; D005374:Filtration / Q000379:methods; D005921:Glomerulonephritis / Q000628:therapy*; D005923:Glomerulosclerosis, Focal Segmental / Q000150:complications / Q000628:therapy*; D006801:Humans; D008077:Lipoproteins, LDL / Q000302:isolation & purification*; D008297:Male; D008875:Middle Aged; D009404:Nephrotic Syndrome / Q000209:etiology / Q000628:therapy*; D010956:Plasmapheresis / Q000379:methods
D008077:Lipoproteins, LDL